🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for GLP-1

Dietary Peanuts and Nutrition-Related Outcomes NCT07244458NA1 site📍 Clevland Ian J. Neeland, MD · Tests: Peanuts, Dual-energy X-ray absorptiometry (DEXA) scans Physical Inactivity and Appetite Regulation NCT06240208NA1 site📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: Inactivity Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy NCT07518407NA1 site📍 Columbia University of South Carolina · Tests: SWITCH Diets - Mobile Nutrition Behavioral Intervention Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness NCT06487832NA1 site📍 Tübingen University Hospital Tuebingen · Tests: Subcutaneous GLP1-RA, Subcutaneous placebo Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) NCT07654361Phase 371 sites📍 Birmingham📍 Birmingham📍 Phoenix Gasherbrum Bio, Inc., a wholly owned subsidiary of Structur… · Tests: Aleniglipron, Placebo IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion NCT07361874NA1 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Intervention 1: Adrenalectomy, Intervention 2: Semaglutide Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss NCT07592546Phase 41 site📍 Montreal Alain Dagher · Tests: semaglutide Rutazyme Lemon Fermented Product Capsules for Metabolic Function in Adults With Obesity NCT07540949NA1 site📍 Taoyuan National Taiwan Sport University · Tests: Rutazyme® Lemon Fermented Product Capsule, Placebo Capsule (Maltodextrin; GLUCIDEX®12) Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema NCT07012642EARLY Phase 12 sites📍 Red Bank📍 Westwood Advanced Reconstructive Surgery Alliance · Tests: GLP-1 Receptor Agonists Strength Training Response of Muscle in GLP-1 Users NCT07104539NA1 site📍 Blacksburg Virginia Polytechnic Institute and State University · Tests: Strength Training, Wait first, then strength training Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome NCT05586802Phase 31 site📍 Lausanne Georgios Papadakis · Tests: Anastrozole, Semaglutide, human chorionic gonadotropin, Testosterone gel Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Receptor (GLP-1 RA) Agonist Prior to Anesthesia NCT06654219NA1 site📍 Houston The University of Texas Health Science Center, Houston · Tests: GLP-1 RA users with prolonged fasting instructions, GLP-1 RA users with standard NPO instructions A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) NCT07654374Phase 374 sites📍 Birmingham📍 Chandler📍 Phoenix Gasherbrum Bio, Inc., a wholly owned subsidiary of Structur… · Tests: aleniglipron, aleniglipron, aleniglipron, Placebo Very Low Carbohydrate Diets and Glucagon Response in T1DM NCT04200391NA1 site📍 Boston Boston Children's Hospital · Tests: Very low carbohydrate diet Tirzepatide Impact Assessment Study NCT07740291NA1 site📍 Lubbock Texas Tech University · Tests: GLP-1 Receptor Agonist Therapy, Structured Lifestyle Intervention Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity NCT07091500NA1 site📍 St Louis Washington University School of Medicine · Tests: Exercise training, Semaglutide, Therapy Cessation Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes NCT05822609Phase 24 sites📍 Aurora📍 Seattle📍 Spokane University of Washington · Tests: Semaglutide, Placebo Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes NCT07210684NA1 site📍 Addison Nanjing Nutrabuilding Bio-tech Co., Ltd. · Tests: Placebo 400 mg, Dihydroberberine（DHB）400 mg Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients NCT06774079Phase 41 site📍 Miami University of Miami · Tests: Tirzepatide, Mediterranean diet Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV NCT04174755NA1 site📍 Dublin University College Dublin · Tests: Semaglutide Injectable Product, Standard of care Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors NCT07506356n/a1 site📍 Geneva University Hospital, Geneva The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction NCT05499702Phase 21 site📍 Rochester Adrian Vella · Tests: Caloric Restriction, Hyperglycemic clamp Slowly Digestible Carbohydrates for GLP-1 Secretion NCT07572513NA1 site📍 West Lafayette Purdue University · Tests: Maltodextrin (Placebo), Raw Corn Starch Strategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET) NCT06271200NA1 site📍 Zhunan National Health Research Institutes, Taiwan · Tests: Strategic lifestyle and drug interventions, Control Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists. NCT07653412n/a1 site📍 Athens National and Kapodistrian University of Athens · Tests: Semaglutide or Tirzepatide A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2) NCT07101939Phase 27 sites📍 Belgrade📍 Belgrade📍 Belgrade Actimed Therapeutics Ltd · Tests: (S)-pindolol benzoate, Semaglutide, Placebo to (S)-pindolol benzoate Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy NCT06903923Phase 21 site📍 Charlottesville University of Virginia · Tests: GLP-1 receptor agonist, Lifestyle intervention Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes NCT06706284Phase 42 sites📍 San Antonio📍 San Antonio Marzieh Salehi · Tests: Semaglutide Injectable Product, Placebo A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity NCT07243171Phase 1, Phase 21 site📍 Beijing Hangzhou Sciwind Biosciences Co., Ltd. · Tests: ecnoglutide tablets, placebo with matching dosage Tirzepatide for Alcohol Use Disorder NCT06994338Phase 21 site📍 Los Angeles University of Southern California · Tests: Tirzepatide, Placebo injections
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy